Page 234 - medicina-integrativa_compress

228 PARTE II, SECCIÓN 3 ENFERMEDADES INFECCIOSAS

glutathione precursor. In Proceedings of the Eighth International In Proceedings of the Eleventh International Conference on AIDS
Conference on AIDS, Amsterdam, 2:B207, 1992. (Abstract No. B6040), 1996.
11. Buhl R, Jaffe HA, Holroyd KJ, et al: Systemic glutathione deficiency 23. Stoss M, Van Wely M, Musielsky H, et al: Study on local
in symptom-free HIV-seropositive individuals. Lancet 2:1294-1298, inflammatory reactions and other parameters during subcutaneous
1989. mistletoe application in HIV-positive patients and HIV-negative
12. Akerlund B, Jarstrand C, Lindeke B, et al: Effect of N-acetylcysteine subjects over a period of eighteen weeks. Arzneimitteforschung
treatment on HIV-1 infection: A double-blind, placebo controlled 49:366-373, 1999.
trial. Eur J Clin Pharmacol 50:457-461, 1996. 24. Milk thistle fruit. In Blumenthal M, Goldberg A, Brinckman J (eds):
13. Famularo G, Moretti S, Marcellini S, et al: Acetyl-carnitine Herbal medicine: Expanded Commission E Monographs. Newton MA,
deficiency in AIDS patients with neurotoxicity on treatment with Lippincott Williams & Wilkins, 2000, pp 257-263.
antiretroviral nucleoside analogues. AIDS 11:185-190, 1997. 25. Flora K, Hahn M, Rosen H, Benner K: Milk thistle (Silybum
14. Hart AM, Wilson AD, Montovani C, et al: Acetyl-L-carnitine: marianum) for the therapy of liver disease. Am J Gastroenterol
A pathogenesis-based treatment for HIV-associated antiretroviral 93:139-143, 1998.
toxic neuropathy. AIDS 18:1549-1560, 2004. 26. Heber D, Yip I, Ashley JM, et al: Cholesterol-lowering effects of a
15. De Simone C, Tzantzoglou S, Famularo G, et al: High-dose proprietary Chinese red-yeast-rice dietary supplement. Am J Clin
L-carnitine improves immunologic and metabolic parameters Nutr 69:231-236, 1999.
in AIDS patients. Immunopharmacol Immunotoxicol 15:1-12, 27. Mills E, Montori V, Perri D, et al: Natural health product–HIV drug
1993. interactions: A systematic review. Int J STD AIDS 16:181-186, 2005.
16. Shabert JK, Wilmore DW: Glutamine deficiency as a cause of human 28. Taylor D: Effects of behavioral stress management program on
immunodeficiency virus wasting. Med Hypotheses 46: anxiety, mood, self-esteem, and T-cell count in HIV-positive men.
252-256, 1996. Psychol Rep 76:451-457, 1995.
17. Heiser CR, Ernst JA, Barrett JT, et al: Probiotics, soluble fiber, and 29. Fletcher M, Schneiderman N: Cognitive behavioral stress
L-glutamine (GLN) reduce nelfinavir (NFV)- or lopinavir/ritonavir management decreases dysphoric mood and herpes simplex virus-
(LPV/r)-related diarrhea. J Int Assoc Physicians AIDS Care 3: type 2 antibody titers in symptomatic HIV-seropositive gay men.
121-129, 2004. J Consul Clin Psychol 65:31-43, 1997.
18. Turner MJ, Angel JB, Woodend K, Giguere P: The efficacy of 30. McCain NL, Zeller JM, Cella DF, et al: The influence of stress
calcium carbonate in the treatment of protease inhibitor-induced management training in HIV disease. Nurs Res 45:246-253, 1996.
persistent diarrhea in HIV-infected patients. HIV Clin Trials 5:19- 31. Robinson FP, Mathews HL, Witek-Janusek L: Psycho-endocrin e-immune
24, 2004. response to mindfulness-based stress reduction in individuals
19. Jensen-Fangel S, Justesen US, Black FT, et al: Management of infected with the human immunodeficiency virus: A quasi-
protease inhibitor-associated diarrhea. Clin Infect Dis 30:908-914, experimental study. J Altern Complement Med 9:683-694, 2003.
2000. 32. Sanzero L: Effects of cognitive-behavioral interventions on quality of
20. Burack J, Cohen MR, Hahn JA, Abrams DI: Pilot randomized life in persons with HIV. Int J Nurs Stud 36:223-233, 1999.
controlled trials of Chinese herbal treatments for HIV-associated 33. Shlay JC, Chaloner K, Max MB, et al: Acupuncture and amitriptyline
symptoms. J Acquir Immune Defic Syndr Hum Retrovirol 12:386- for pain due to HIV-related peripheral neuropathy. JAMA 280:
393, 1996. 1590-1595, 1998.
21. Christen L, Loy M, Schaller S, et al: Randomized, placebo-controlled 34. Scafidi F, Field T: Massage therapy improves behavior in
trial of Chinese herb therapy for HIV-1-infected individuals. neonates born to HIV-positive mothers. J Pediatr Psychol 21:
J Acquir Immune Defic Syndr J AIDS 22:56-64, 1999. 889-897, 1996.
22. Durant J: A multicenter, randomized, double-blind, 35. Ironsen G, Field T: Massage therapy is associated with enhancement
placebo-controlled trial of efficacy and safety of Buxus sempervirens L. of the immune system’s cytotoxic capacity. Int J Neurosci 84:
preparations (SPV-30) in HIV-infected asymptomatic patients. 205-217, 1996.